Overview Mesenchymal Stromal Cells (MSC´s) in Renal Lupus Status: Recruiting Trial end date: 2022-12-01 Target enrollment: Participant gender: Summary Phase II Clinical Trial to Assess the dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (MSCs) in Severe Renal Systemic Lupus Erythematosus (SLE). Phase: Phase 2 Details Lead Sponsor: Universidad de los Andes, ChileTreatments: CyclophosphamideMethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate